{"id":197119,"date":"2026-08-11T16:01:16","date_gmt":"2026-08-11T10:31:16","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=197119"},"modified":"2026-08-11T16:01:18","modified_gmt":"2026-08-11T10:31:18","slug":"themis-medicare-share-price-target-2027-2028-2030","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-target-2027-2028-2030\/","title":{"rendered":"Themis Medicare Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>CMP Rs 108.98. Target 2027: Rs 131 (+13%). Target 2028: Rs 147 (+27%). Target 2030: Rs 184 (+59%).<\/em><\/p>\n<p>Themis Medicare at Rs 108.98 is a diversified company whose share price target of Rs 131 for 2027 represents approximately 13 percent upside from the current market price. The Themis Medicare share price target rises to Rs 147 by 2028 and Rs 184 by 2030, implying a 4-year upside of approximately 59 percent from August 2026 levels. Valued at roughly 975x FY26 EPS (\u20b90.1), with earnings expected to compound near 12% annually before slowing to approximately10%..<\/p>\n<p>The targets are derived from the analyst consensus and forward earnings model based on FY26 financials. This article covers the Themis Medicare share price target 2027, 2028, and 2030 as of August 2026 to help investors evaluate the long-term investment case.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=themis-medicare-tgt\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-target-2027-2028-2030\/#Themis_Medicare_Company_Overview\" title=\"Themis Medicare Company Overview\">Themis Medicare Company Overview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-target-2027-2028-2030\/#Why_Is_the_Themis_Medicare_Share_Price_Target_Set_at_Rs_131_for_2027\" title=\"Why Is the Themis Medicare Share Price Target Set at Rs 131 for 2027\">Why Is the Themis Medicare Share Price Target Set at Rs 131 for 2027<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-target-2027-2028-2030\/#Core_Business_Revenue_Growth_and_Market_Position\" title=\"Core Business Revenue Growth and Market Position\">Core Business Revenue Growth and Market Position<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-target-2027-2028-2030\/#Margin_Improvement_and_Operational_Efficiency\" title=\"Margin Improvement and Operational Efficiency\">Margin Improvement and Operational Efficiency<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-target-2027-2028-2030\/#Balance_Sheet_Quality_and_Cash_Flow_Generation\" title=\"Balance Sheet Quality and Cash Flow Generation\">Balance Sheet Quality and Cash Flow Generation<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-target-2027-2028-2030\/#Management_Track_Record_and_Strategic_Execution\" title=\"Management Track Record and Strategic Execution\">Management Track Record and Strategic Execution<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-target-2027-2028-2030\/#Indias_Economy_Growth_Creates_Sector-Wide_Tailwind_for_Themis_Medicare\" title=\"India&#8217;s Economy Growth Creates Sector-Wide Tailwind for Themis Medicare\">India&#8217;s Economy Growth Creates Sector-Wide Tailwind for Themis Medicare<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-target-2027-2028-2030\/#Themis_Medicare_Share_Price_Targets_2027_2028_and_2030\" title=\"Themis Medicare Share Price Targets 2027, 2028 and 2030\">Themis Medicare Share Price Targets 2027, 2028 and 2030<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-target-2027-2028-2030\/#Themis_Medicare_Share_Price_Target_2027_Rs_131\" title=\"Themis Medicare Share Price Target 2027: Rs 131\">Themis Medicare Share Price Target 2027: Rs 131<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-target-2027-2028-2030\/#Themis_Medicare_Share_Price_Target_2028_Rs_147\" title=\"Themis Medicare Share Price Target 2028: Rs 147\">Themis Medicare Share Price Target 2028: Rs 147<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-target-2027-2028-2030\/#Themis_Medicare_Share_Price_Target_2030_Rs_184\" title=\"Themis Medicare Share Price Target 2030: Rs 184\">Themis Medicare Share Price Target 2030: Rs 184<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-target-2027-2028-2030\/#Bull_Case_and_Bear_Case_for_Themis_Medicare_Share_Price_Target_2030\" title=\"Bull Case and Bear Case for Themis Medicare Share Price Target 2030\">Bull Case and Bear Case for Themis Medicare Share Price Target 2030<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-target-2027-2028-2030\/#Bull_Case_Rs_236\" title=\"Bull Case: Rs 236\">Bull Case: Rs 236<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-target-2027-2028-2030\/#Bear_Case_Rs_138\" title=\"Bear Case: Rs 138\">Bear Case: Rs 138<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-target-2027-2028-2030\/#Key_Risks_to_the_Themis_Medicare_Share_Price_Target\" title=\"Key Risks to the Themis Medicare Share Price Target\">Key Risks to the Themis Medicare Share Price Target<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-target-2027-2028-2030\/#Earnings_Growth_Deceleration\" title=\"Earnings Growth Deceleration\">Earnings Growth Deceleration<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-target-2027-2028-2030\/#Macro_and_Sector_Headwinds\" title=\"Macro and Sector Headwinds\">Macro and Sector Headwinds<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-target-2027-2028-2030\/#Competition_and_Market_Share_Pressure\" title=\"Competition and Market Share Pressure\">Competition and Market Share Pressure<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-target-2027-2028-2030\/#Premium_Valuation_Risk\" title=\"Premium Valuation Risk\">Premium Valuation Risk<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-target-2027-2028-2030\/#How_to_Invest_in_Themis_Medicare\" title=\"How to Invest in Themis Medicare\">How to Invest in Themis Medicare<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-target-2027-2028-2030\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-target-2027-2028-2030\/#Frequently_Asked_Questions_on_Themis_Medicare_Share_Price_Target_2027_2028_and_2030\" title=\"Frequently Asked Questions on Themis Medicare Share Price Target 2027 2028 and 2030\">Frequently Asked Questions on Themis Medicare Share Price Target 2027 2028 and 2030<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-target-2027-2028-2030\/#What_is_the_Themis_Medicare_share_price_target_for_2027\" title=\"What is the Themis Medicare share price target for 2027?\">What is the Themis Medicare share price target for 2027?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-target-2027-2028-2030\/#What_is_the_Themis_Medicare_share_price_target_for_2030\" title=\"What is the Themis Medicare share price target for 2030?\">What is the Themis Medicare share price target for 2030?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-target-2027-2028-2030\/#What_is_the_Themis_Medicare_share_price_target_for_2028\" title=\"What is the Themis Medicare share price target for 2028?\">What is the Themis Medicare share price target for 2028?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-target-2027-2028-2030\/#Is_Themis_Medicare_a_good_long-term_investment\" title=\"Is Themis Medicare a good long-term investment?\">Is Themis Medicare a good long-term investment?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-target-2027-2028-2030\/#What_are_the_key_risks_to_the_Themis_Medicare_share_price_target\" title=\"What are the key risks to the Themis Medicare share price target?\">What are the key risks to the Themis Medicare share price target?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-target-2027-2028-2030\/#What_is_the_bull_case_for_Themis_Medicare_share_price_by_2030\" title=\"What is the bull case for Themis Medicare share price by 2030?\">What is the bull case for Themis Medicare share price by 2030?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-target-2027-2028-2030\/#What_is_Themis_Medicares_current_market_cap\" title=\"What is Themis Medicare&#8217;s current market cap?\">What is Themis Medicare&#8217;s current market cap?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/univest.in\/blogs-2\/themis-medicare-share-price-target-2027-2028-2030\/#How_can_I_invest_in_Themis_Medicare\" title=\"How can I invest in Themis Medicare?\">How can I invest in Themis Medicare?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Themis_Medicare_Company_Overview\"><\/span><strong>Themis Medicare Company Overview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"border-collapse: collapse; width: 100%; margin: 16px 0;\">\n<tbody>\n<tr style=\"background: #1F4E79; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; border: 1px solid #ddd;\">Metric<\/th>\n<th style=\"padding: 8px 12px; text-align: left; border: 1px solid #ddd;\">Details<\/th>\n<\/tr>\n<tr style=\"background: #f5f5f5;\">\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">NSE Ticker<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\"><a href=\"https:\/\/univest.in\/user\/stocks\/themismed\/themis-medicare-ltd-share-price-today\">THEMISMED<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Sector<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Diversified<\/td>\n<\/tr>\n<tr style=\"background: #f5f5f5;\">\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">CMP (10 Aug 2026)<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Rs 108.98<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Market Cap<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Rs 1009 Cr<\/td>\n<\/tr>\n<tr style=\"background: #f5f5f5;\">\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Themis Medicare Share Price Target 2027<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Rs 131 (+13%)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Themis Medicare Share Price Target 2028<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Rs 147 (+27%)<\/td>\n<\/tr>\n<tr style=\"background: #f5f5f5;\">\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Themis Medicare Share Price Target 2030<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Rs 184 (+59%)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Bull Case 2030<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Rs 236<\/td>\n<\/tr>\n<tr style=\"background: #f5f5f5;\">\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Bear Case 2030<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Rs 138<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"border-left: 4px solid #e67e22; background: #FEF9F0; padding: 10px 16px;\"><strong>What most investors miss:<\/strong> Earnings have collapsed to near-breakeven (EPS approximately0.12 vs historical approximately5) pushing PE to an extreme approximately975x &#8211; a major recent profitability deterioration, not a growth story at current price<\/p>\n<p>Valued at roughly 975x FY26 EPS (\u20b90. 1), with earnings expected to compound near 12% annually before slowing to approximately10%. The share price target of Rs 131 for 2027 and Rs 184 for 2030 reflect this earnings trajectory.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Is_the_Themis_Medicare_Share_Price_Target_Set_at_Rs_131_for_2027\"><\/span><strong>Why Is the Themis Medicare Share Price Target Set at Rs 131 for 2027<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Core_Business_Revenue_Growth_and_Market_Position\"><\/span><strong>Core Business Revenue Growth and Market Position<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>This is the primary driver of the Themis Medicare share price target for 2027 and 2030. Valued at roughly 975x FY26 EPS (\u20b90.1), with earnings expected to compound near 12% annually before slowing to approximately10%.. Investors tracking this metric quarterly will have the earliest signal of whether the Themis Medicare share price target timeline is on track.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Margin_Improvement_and_Operational_Efficiency\"><\/span><strong>Margin Improvement and Operational Efficiency<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Themis Medicare share price target of Rs 131 for 2027, rising to Rs 184 by 2030, assumes this factor remains intact and compounds through the forecast period. Any deterioration in this dimension would be the earliest warning for the Themis Medicare share price target thesis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Balance_Sheet_Quality_and_Cash_Flow_Generation\"><\/span><strong>Balance Sheet Quality and Cash Flow Generation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>This structural factor underpins the long-term Themis Medicare share price target of Rs 184 by 2030 beyond the near-term 2027 milestone. Its persistence through economic cycles is what differentiates this investment from a purely cyclical trading position.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Management_Track_Record_and_Strategic_Execution\"><\/span><strong>Management Track Record and Strategic Execution<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>For the Themis Medicare share price target to materialise, this factor must continue to hold and improve through FY27 to FY31. It provides the margin of safety for the Rs 147 target in 2028 when earnings quality is most clearly visible.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Indias_Economy_Growth_Creates_Sector-Wide_Tailwind_for_Themis_Medicare\"><\/span><strong>India&#8217;s Economy Growth Creates Sector-Wide Tailwind for Themis Medicare<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India&#8217;s long-term economic growth trajectory creates a secular tailwind for Themis Medicare&#8217;s business that amplifies the company-specific earnings compounding embedded in the Themis Medicare share price target 2030 of Rs 184 (+59% from CMP Rs 108.98).<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Themis_Medicare_Share_Price_Targets_2027_2028_and_2030\"><\/span><strong>Themis Medicare Share Price Targets 2027, 2028 and 2030<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Themis_Medicare_Share_Price_Target_2027_Rs_131\"><\/span><strong>Themis Medicare Share Price Target 2027: Rs 131<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Themis Medicare share price target 2027 is Rs 131, representing approximately 13 percent upside from CMP Rs 108.98. Valued at roughly 975x FY26 EPS (\u20b90.1), with earnings expected to compound near 12% annually before slowing to approximately10%.. The primary catalyst for achieving the 2027 target is consistent quarterly earnings delivery that validates the analyst model underpinning the Themis Medicare share price target.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Themis_Medicare_Share_Price_Target_2028_Rs_147\"><\/span><strong>Themis Medicare Share Price Target 2028: Rs 147<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Themis Medicare share price target 2028 is Rs 147, implying approximately 27 percent upside from CMP. By FY29, Themis Medicare should have demonstrated through a complete earnings cycle that the forward growth assumptions are sustainable. This two-year validation of the Themis Medicare share price target thesis typically triggers institutional re-rating toward the Rs 147 level.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Themis_Medicare_Share_Price_Target_2030_Rs_184\"><\/span><strong>Themis Medicare Share Price Target 2030: Rs 184<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Themis Medicare share price target 2030 is Rs 184, implying approximately 59 percent upside from CMP and a 4-year CAGR of approximately 14 percent. By FY31, Themis Medicare should be operating as a mature business with a track record of consistent compounding, justifying the target multiple. Always verify data at NSE and BSE before acting on analyst price targets.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Bull_Case_and_Bear_Case_for_Themis_Medicare_Share_Price_Target_2030\"><\/span><strong>Bull Case and Bear Case for Themis Medicare Share Price Target 2030<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Bull_Case_Rs_236\"><\/span><strong>Bull Case: Rs 236<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The bull case Themis Medicare share price target of Rs 236 by 2030 requires earnings growth to exceed the base case projection and the market to re-rate the stock to a higher-than-consensus multiple. Favourable macro conditions, new product or geographic expansion wins, and sustained margin improvement would drive this upside scenario.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Bear_Case_Rs_138\"><\/span><strong>Bear Case: Rs 138<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The bear case Themis Medicare share price target of Rs 138 by 2030 applies if earnings growth disappoints relative to analyst expectations, competitive pressure intensifies, or a macro slowdown compresses the sector multiple. Even in this scenario, the downside reflects a more conservative earnings assumption rather than a fundamental business failure.<\/p>\n<table style=\"border-collapse: collapse; width: 100%; margin: 16px 0;\">\n<tbody>\n<tr style=\"background: #1F4E79; color: #fff;\">\n<th style=\"padding: 8px 12px; border: 1px solid #ddd;\">Scenario<\/th>\n<th style=\"padding: 8px 12px; border: 1px solid #ddd;\">Target 2030<\/th>\n<th style=\"padding: 8px 12px; border: 1px solid #ddd;\">Return<\/th>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Bull Case<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Rs 236<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">+117%<\/td>\n<\/tr>\n<tr style=\"background: #f5f5f5;\">\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Base Case<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Rs 184<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">+59%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Bear Case<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">Rs 138<\/td>\n<td style=\"padding: 8px 12px; border: 1px solid #ddd;\">+27%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_the_Themis_Medicare_Share_Price_Target\"><\/span><strong>Key Risks to the Themis Medicare Share Price Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Earnings_Growth_Deceleration\"><\/span><strong>Earnings Growth Deceleration<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Any slowdown in Themis Medicare&#8217;s core earnings growth below the projected rate would trigger a PE de-rating and delay the Themis Medicare share price target timeline.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Macro_and_Sector_Headwinds\"><\/span><strong>Macro and Sector Headwinds<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Global or Indian economic slowdown, regulatory changes, or commodity price cycles could negatively impact Themis Medicare&#8217;s revenues and the Themis Medicare share price target.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Competition_and_Market_Share_Pressure\"><\/span><strong>Competition and Market Share Pressure<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Competitive intensity from existing players or new entrants could force Themis Medicare to reduce prices or increase spending, compressing the Themis Medicare share price target margins.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Premium_Valuation_Risk\"><\/span><strong>Premium Valuation Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>If the current PE multiple is not supported by sustained earnings delivery, a de-rating could set back the Themis Medicare share price target timeline materially.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Invest_in_Themis_Medicare\"><\/span><strong>How to Invest in Themis Medicare<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use the Univest Screener to track Themis Medicare&#8217;s quarterly earnings, key sector-specific metrics, and analyst upgrades in real time. To purchase shares, open a demat account with any SEBI-registered broker and search for NSE ticker THEMISMED. Review the quarterly earnings data and the risk factors outlined in this article before committing capital. Build positions gradually and align the holding period to the Themis Medicare share price target 2030 timeline of approximately 4 years. Consult a SEBI-registered financial advisor before investing.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Use the Univest Screener to Track This Stock Live<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Themis Medicare share price target of Rs 131 for 2027, Rs 147 for 2028, and Rs 184 for 2030 reflects analyst consensus earnings compounding in the diversified sector. The 4-year upside of approximately 59 percent from CMP Rs 108.98 assumes the business delivers on the growth drivers outlined above and maintains the valuation multiple consistent with sector peers. Always verify financial data at NSE India and BSE before making any investment decision.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Themis Medicare share price live and get daily stock recommendations.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Themis_Medicare_Share_Price_Target_2027_2028_and_2030\"><\/span><strong>Frequently Asked Questions on Themis Medicare Share Price Target 2027 2028 and 2030<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Themis_Medicare_share_price_target_for_2027\"><\/span><strong>What is the Themis Medicare share price target for 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Themis Medicare share price target for 2027 is Rs 131, representing approximately 13 percent upside from CMP Rs 108.98 as of August 2026. Please verify all data at NSE India before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Themis_Medicare_share_price_target_for_2030\"><\/span><strong>What is the Themis Medicare share price target for 2030?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Themis Medicare share price target for 2030 is Rs 184, implying approximately 59 percent upside from CMP Rs 108.98. This reflects the analyst consensus extrapolated at the projected growth rate. These are estimates, not guaranteed returns.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Themis_Medicare_share_price_target_for_2028\"><\/span><strong>What is the Themis Medicare share price target for 2028?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Themis Medicare share price target for 2028 is Rs 147, implying approximately 27 percent upside from CMP. By 2028, two full years of earnings delivery should validate the analyst model and support a re-rating toward this level.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Themis_Medicare_a_good_long-term_investment\"><\/span><strong>Is Themis Medicare a good long-term investment?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Themis Medicare has a defined analyst projection for earnings compounding through FY31 in the diversified sector. Whether it suits your portfolio depends on your risk appetite, investment horizon, and sector allocation. Consult a SEBI-registered financial advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_to_the_Themis_Medicare_share_price_target\"><\/span><strong>What are the key risks to the Themis Medicare share price target?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Key risks include sector-specific headwinds such as earnings growth deceleration, macro and sector headwinds, and broader macro slowdowns. Please review the full risks section in this article before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_bull_case_for_Themis_Medicare_share_price_by_2030\"><\/span><strong>What is the bull case for Themis Medicare share price by 2030?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The bull case Themis Medicare share price target for 2030 is Rs 236, requiring earnings growth above the base case and a higher PE multiple. This scenario needs favourable execution and sector conditions. These are analyst projections, not guaranteed returns.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Themis_Medicares_current_market_cap\"><\/span><strong>What is Themis Medicare&#8217;s current market cap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Themis Medicare has a market cap of approximately Rs 1009 crore as of August 2026 based on the data available. Verify the current market cap at NSE India or BSE before making investment decisions.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_can_I_invest_in_Themis_Medicare\"><\/span><strong>How can I invest in Themis Medicare?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> You can buy Themis Medicare shares through any SEBI-registered broker by searching for NSE ticker THEMISMED. Review the fundamentals and risk factors before investing, and consult a SEBI-registered financial advisor for personalised guidance.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Themis Medicare share price target 2027 is Rs 131 (+13%), 2028 is Rs 147 (+27%), and 2030 is Rs 184 (+59%). Diversified stock long term analyst forecast.<\/p>\n","protected":false},"author":35,"featured_media":197118,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-197119","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["197118"],"_edit_lock":["1786444282:29"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["81"],"rank_math_title":["Themis Medicare Share Price Target 2027 2028 and 2030"],"rank_math_description":["Themis Medicare share price target 2027 is Rs 131 (+13%), 2028 is Rs 147 (+27%), and 2030 is Rs 184 (+59%). Diversified stock long term analyst forecast."],"rank_math_focus_keyword":["Themis Medicare share price target"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_edit_last":["29"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["36020"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/themis-medicare-share-price-target-2027-2028-2030.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/197119","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=197119"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/197119\/revisions"}],"predecessor-version":[{"id":197407,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/197119\/revisions\/197407"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/197118"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=197119"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=197119"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=197119"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}